# Risk of Asymptomatic Cerebral Embolism During AF Ablation With AI-HPSD Strategy Versus Standard Settings

> **NCT04408716** · NA · COMPLETED · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 100 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Ablation Index Guided High-Power Short-Duration Strategy
- **PROCEDURE:** Standard Radiofrequency Ablation Technique

## Key facts

- **NCT ID:** NCT04408716
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-17
- **Primary completion:** 2021-09-13
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408716, "Risk of Asymptomatic Cerebral Embolism During AF Ablation With AI-HPSD Strategy Versus Standard Settings". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04408716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*